Allworth Financial LP Accelerate Diagnostics, Inc Transaction History

Allworth Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$0.46 - $0.77 $70,840 - $118,580	154,000 New	154,000 $107,000
Q2 2022 Jul 13, 2022	BUY	$0.54 - $1.41 $28,080 - $73,320	52,000 Added 50.98%	154,000 $153,000
Q1 2022 Apr 22, 2022	BUY	$1.4 - $5.15 $72,800 - $267,800	52,000 Added 104.0%	102,000 $147,000
Q4 2021 Jan 21, 2022	BUY	$4.27 - $6.97 $42,699 - $69,700	10,000 Added 25.0%	50,000 $261,000
Q1 2021 Apr 29, 2021	BUY	$7.99 - $15.0 $71,910 - $135,000	9,000 Added 29.03%	40,000 $333,000
Q4 2020 Jan 26, 2021	BUY	$7.04 - $11.7 $218,240 - $362,700	31,000 New	31,000 $235,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.